Category Archives: News

A new targeted therapy for metastatic castration-resistant prostate cancer (mCRPC), Akeega®, is already funded and available in Spain after approval of pricing and reimbursement by the National Healthcare System. This step constitutes a significant advance in the approach to this pathology and highlights the key role of molecular diagnosis in clinical practice.     January […]

October 24, 2025.    At the Health in Code Group, we understand that our commitment to sustainability is not merely an add-on, but a cross-cutting way of working and serving the health of people and the planet.   In our new 2024 Sustainability Report, we present in a highly detailed and transparent way our latest […]

Proteomics is the branch of biology that studies the complete set of proteins produced by an organism, tissue, cell, or biological system at a given moment. The proteomics offered by Olink enables secretome analysis by combining high sensitivity, specificity, and scalability, making it especially valuable in biomedicine, oncology, immunology, and complex diseases. Olink has accredited […]

We have obtained ISO 45001 certification, which recognizes our effectiveness in caring for our team and work environment. This recognition confirms that an organization manages occupational health and safety (OHS) effectively through a structured, proactive system based on continuous improvement.   Madrid, June 30, 2025.   Health in Code has reached a new milestone in […]

Our colleague, a medical specialist in Microbiology and Parasitology, has spent years contributing to scientific knowledge in microbiology and public health. As chair of the Scientific Commission on Microbiology within SEMEDLAB’s scientific committee, he will promote innovation in the genetic applications of microbiology.     Madrid, June 17, 2025.    Genetic applications in microbiology have […]

Our colleague Mireia Boluda, project coordinator of our R+D team, has taken part in a paper published in the journal Human Reproduction in collaboration with IVI RMA.     Madrid, February 11, 2025.    In assisted reproductive treatments, embryos are tested before implantation to minimize the risk of miscarriage and transmission of certain genetic conditions. […]

In an event attended by leading figures from the worlds of sports, medicine, and the media, the importance of personalized and precision medicine for the future of oncology was emphasized.     Madrid, January 30, 2025.   “We can prevent cancer” was the motto of the conference organized by the Spanish Olympic Committee to raise […]

Madrid, December 30, 2024.   Health in Code’s R+D team has developed a groundbreaking method for the genetic diagnosis of hereditary alpha tryptasemia. This advance constitutes a milestone in the molecular diagnosis of this genetic disease caused by alterations in the TPSAB1 gene.   Due to the non-specificity of its symptoms (severe allergic reactions, skin […]